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Abstract
Lipoprotein(a) (Lp(a)) is an important causal cardiovascular risk factor, with serum Lp(a) levels predicting atherosclerotic
heart disease and genetic determinants of Lp(a) levels showing association with myocardial infarction. Lp(a) levels vary
widely between populations, with African-derived populations having nearly 2-fold higher Lp(a) levels than European
Americans. We investigated the genetic basis of this difference in 4464 African Americans from the Jackson Heart Study
(JHS) using a panel of up to 1447 ancestry informative markers, allowing us to accurately estimate the African ancestry
proportion of each individual at each position in the genome. In an unbiased genome-wide admixture scan for frequency-
differentiated genetic determinants of Lp(a) level, we found a convincing peak (LOD=13.6) at 6q25.3, which spans the LPA
locus. Dense fine-mapping of the LPA locus identified a number of strongly associated, common biallelic SNPs, a subset of
which can account for up to 7% of the variation in Lp(a) level, as well as .70% of the African-European population
differences in Lp(a) level. We replicated the association of the most strongly associated SNP, rs9457951 (p=6610
222, 27%
change in Lp(a) per allele, ,5% of Lp(a) variance explained in JHS), in 1,726 African Americans from the Dallas Heart Study
and found an even stronger association after adjustment for the kringle(IV) repeat copy number. Despite the strong
association with Lp(a) levels, we find no association of any LPA SNP with incident coronary heart disease in 3,225 African
Americans from the Atherosclerosis Risk in Communities Study.
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Introduction
Lipoprotein(a) (Lp(a)) is a subclass of lipoproteins, consisting of a
low-density lipoprotein (LDL)-like particle covalently bound to the
LPA gene product. Serum Lp(a) levels are a risk factor for
cardiovascular disease, albeit with more modest effect than LDL-
cholesterol [1–3]. Common variants within the LPA gene have
been associated with myocardial infarction, suggesting a causal
link between Lp(a) and atherosclerotic heart disease [4–7].
The genetic determinants of Lp(a) levels have been investigated
extensively both within and between ethnic groups. Lp(a) is highly
variable, with over 90% of the variance in Lp(a) levels in European
Americans attributable to variation within the LPA gene [4]; the
corresponding percentage in African Americans is ,80% [5]. LPA
includes a well-characterized 5.6 kilobase-pair copy-number
variant (CNV) that encodes a kringle(IV) domain [6,7]. Higher
copy numbers for this domain are associated with lower Lp(a)
levels [8], presumably due to impaired secretion of the larger
PLoS ONE | www.plosone.org 1 January 2011 | Volume 6 | Issue 1 | e14581protein product [9]. Biallelic SNPs and other CNVs also appear to
contribute independently to Lp(a) level [10].
Lp(a) levels vary widely between populations [11], with some
populations of African ancestry having nearly 4-fold higher Lp(a)
levels than European Americans [12]. The interethnic differences
in populations seem to be only weakly explained by the kringle(IV)
CNV, thus motivating searches for other responsible variants [10].
Given the association of LPA variants with coronary heart disease
(CHD), identifying these determinants may have clinical implica-
tions for differences in disease prevalence between populations.
Recent genetic association analyses in admixed populations
such as African Americans have highlighted the complexities due
to confounding by ancestry [13]. We have extended our earlier
work on admixture mapping and genetic association analysis in
the Jackson Heart Study (JHS) to the Lp(a) trait and find the
amount of African or European ancestry at the LPA locus is
strongly associated with Lp(a) level. Dense fine-mapping of LPA
identified multiple strongly associated variants, including
rs9457951 and rs10455872, a SNP strongly associated with
myocardial infarction in European populations [14]. A multi-
SNP model explains ,7% of the variation in Lp(a) level and 73%
of the association of local ancestry with this trait. We have
replicated the strongest association (rs9457951) in the Dallas Heart
Study (DHS), and find a stronger effect after adjustment for the
kringle(IV) CNV. Finally, we genotyped 10 SNPs in .3200
African Americans in the Atherosclerosis Risk in Communities
(ARIC) Study and, although we validated the strong association of
LPA local ancestry and genotypes at 7 of the 10 SNPs with Lp(a)
level, we find no significant association of these variables with
incident CHD.
Results
Admixture Mapping for Determinants of Lp(a) Levels
Identifies a Strong Peak at the LPA Locus
We studied a sample of 4605 individuals from the JHS (Table 1),
a community-based observational study of cardiovascular disease
(CVD) in African Americans [15]. We have previously used a
panel of .1400 genotypic markers selected for high differences in
frequency between European Americans and West Africans [16]
to estimate African ancestry across the genome of 4464
individuals. To investigate the genetic basis of African-European
differences in serum Lp(a) levels, we performed genomewide
admixture mapping of the Lp(a) trait (see Methods).
Admixture mapping of Lp(a) reveals a compelling association of
increased African ancestry with Lp(a) case status (upper quintile) at
chromosome 6q25.3 (LOD 13.6, Figure 1). This far exceeds our
threshold of significance of 5 for LOD scores [17] and suggests a
marked association of local ancestry at this locus with Lp(a) level.
In this region, individuals having Lp(a) levels in the upper quintile
had a mean African ancestry of 87.4%, compared to 72.7% for
those having Lp(a) values in the lower quintile (p,2610
216). The
95% credible interval for this peak spans from 158 to 162
megabasepairs (Mb) and includes the LPA gene.
Local Ancestry at the LPA locus is strongly associated
with Lp(a) Levels
In addition to localizing genetic determinants of disease,
estimates of individual ancestry in admixed individuals can be
correlated with continuous phenotypes (see Methods). To further
characterize the admixture peak at the LPA locus, we obtained an
estimate for overall ancestry and for local ancestry at the LPA locus
for each individual in JHS. Looking first at overall ancestry, we
found a 9.961.3% increase in Lp(a) level for each 10% increase in
overall African ancestry (p=6.8610
27). Interestingly, this result is
in keeping with the ,2 fold difference in Lp(a) levels seen in ARIC
between European and African Americans [18], suggesting that
genetic determinants of the association between global ancestry
and Lp(a) levels within an admixed population may prove useful in
explaining differences in Lp(a) levels between African and
European American populations. When we incorporated local
ancestry as a covariate in the linear regression model, we found an
increase of 7.760.5% in Lp(a) level for each 10% increase in local
African ancestry at the LPA locus (p=1.8610
225). Furthermore,
inclusion of the LPA local ancestry rendered the overall ancestry
Table 1. Demographic Characteristics for the Genotyped Jackson Heart Study Participants.
All Unrelated
Unrelated with only African
local ancestry at LPA
Unrelated with European
local ancestry at LPA
Number 4464 3300 1831 615
Male (%) 36.8 37.8 38.4 40.7
Age (mean - years, 6 std.) 55613 56611 57612 57612
BMI (mean - kg/m
2 6 std.) 32673 2 673 2 673 1 66
Type II DM (%) 18.9 20.4 20.6 17.6
Cholesterol or TG-Lowering Medication (%) 12.5 13.6 13.8 14.3
LDL-Cholesterol: unmedicated |
medicated participants (mg/dL)
127636 | 113633 128637 | 113633 128636 | 113635 130638 | 117630
HDL-Cholesterol: unmedicated |
medicated participants (mg/dL)
51614 | 51614 52615 | 52614 52615 | 51614 52614 | 52612
Serum Triglycerides: unmedicated |
medicated participants (mg/dL)
106681 | 1296151 107683 | 1306164 108697 | 1366212 108663 | 123673
Serum Lp(a): unmedicated |
medicated participants (mg/dL)
57644 | 72654 57643 | 73654 62643 | 83657 42637 | 55643
Overall African Ancestry (%) 83698 2 698 5 677 5 612
Characteristics are shown for the 4464 genotyped participants, the 3300 unrelated individuals, the 1831 unrelated individuals with homozygous African local ancestry at
the LPA locus, and the 615 individuals with at least one ancestral European allele at LPA.
doi:10.1371/journal.pone.0014581.t001
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fully explains the ancestry-related differences in Lp(a) levels.
Common LPA SNPs Explain A Modest Percentage of
Variance in Lp(a) Levels
We next performed a fine-mapping study to look for variant(s)
in the LPA gene that can account for the admixture signal at this
locus. Although several common variants as well as the kringle(IV)
repeat have previously been shown to contribute to African-
European differences [10], these earlier studies were performed
without estimates of LPA local ancestry. In such cases, effects
attributed to the repeat or to specific SNPs may reflect
confounding by admixture linkage disequilibrium.
Given that genetic variation at the LPA locus has been shown to
explain .80% of variation in Lp(a) levels [5], we selected a dense
panel of SNPs spanning the LPA locus and extending 10 kb
upstream and downstream (see Methods). This interval includes
LPA and nearly all of LPAL2 (Lp(a)-like 2 precursor). SNP-Lp(a)
associations were evaluated by linear regression, correcting for
global and local ancestry at the LPA locus. As another approach to
potential confounding by differing LD patterns, we tested
association of each SNP separately in a subpopulation of 1831
individuals who had .95% probability of two African ancestral
chromosomes in the region (JHS-AFR-2LPA), thus minimizing
heterogeneity in local ancestry background, and a subpopulation
of 615 individuals with .95% probability of at least one European
ancestral allele (JHS-EUR-1_2LPA; see Table 1 for demographic
characteristics of these subgroups).
Figure 2 and Table S1 present the p-values for association with
Lp(a) for the 59 successfully genotyped SNPs. 24 SNPs had a p-
value less than 0.00085 (corresponding to p=0.05 with Bonferroni
correction for 59 SNPs tested), with the strongest SNPs being
rs9457951 (p=9.2610
226), rs6930542 (p=9.2610
227,r
2=0.994
with rs9457951 in JHS-AFR-2 LPA), rs10455872, (p=1.3610
219)
and rs6922216 (p=5.4610
215,r
2=0.746 with rs9457951 in JHS-
AFR-2LPA). Eighteen of the top 20 SNPs show significant
association in the JHS-AFR-2LPA subpopulation at p,0.00085.
The exceptions were rs10455872, which is nearly fixed in
Figure 1. Affected-Only Statistic at Equally Spaced Points
across the genome for the Lp(a) Admixture Scan. The 95%
credible interval for the peak at 6q25.3 includes the LPA and LPA2
genes.
doi:10.1371/journal.pone.0014581.g001
Figure 2. Graphical Depiction of SNP-Lp(a) Associations in the 6q25.3 region. For each SNP, -log(p-values) given in Table S1 are shown
against chromosomal position (kb). rs9457951 is highlighted in blue, and SNPs in strong (r
2$0.8), moderate (0.8.r
2$0.25) and weak(0.25.r
2$0.10)
and very weak (0.1.r
2) linkage disequilibrium with rs9457951 in the Yoruba HapMap population are depicted by red, yellow, green, and white
diamonds, respectively. The position of the LPA and LPAL2 genes are depicted by green arrows. The chromosomal recombination rate for the Yoruba
population is depicted at the bottom of the plot, in light blue.
doi:10.1371/journal.pone.0014581.g002
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which has an MAF of 0.006 in this subgroup. Notably, for 21 of
the 24 significant SNPs, the allele associated with higher Lp(a)
levels is at higher frequency in the African ancestral subpopula-
tion, providing a strong explanation for the association of African
LPA local ancestry with increased Lp(a) levels. Furthermore, for 4
of the SNPs – rs9457951, rs6930542, rs6922216, rs7755463 – the
allele corresponding to higher Lp(a) levels is nearly absent in JHS-
EUR-2LPA. Pairwise LD values in the African and European local
ancestry subpopulations are shown in Figures 3 and Figure S1.
Effect sizes for individual SNPs are shown in Table 2. For
rs9457951, which is intronic, the effect size is an increase in Lp(a)
level by 2562% per allele. The minor allele frequency for
rs9457951 in JHS is 0.19, and this SNP alone appears to explain
,5% of the residual variance in Lp(a) after adjustment for gender.
The largest effect is seen for rs10455872, which demonstrates an
effect size of 9267% in Lp(a) level per inherited allele. This SNP is
intronic, and was recently shown to explain ,25% of the Lp(a)
variance in a European cohort with a positive association with
myocardial infarction [14]. The high Lp(a) rs10455872 genotype is
correlated with smaller LPA isoform number and thus the strong
contribution to Lp(a) variance likely arises from the effect of the
well known kringle(IV) repeat in the LPA gene.
Common LPA variants explain 7% of the variability in
Lp(a) levels
To determine if a multi-SNP model could better explain the
variability in Lp(a) levels, we performed stepwise linear regression
combined with ANOVA (see Methods). Such analyses are prone
to overestimation if SNP discovery, model building (SNP selection
and parameter estimation) and variance calculations are all
performed using the same individuals. We thus undertook five-
fold cross-validation to more accurately estimate the percentage of
Lp(a) variance explained by common LPA gene polymorphisms
(see Methods). Using this approach, we found that common LPA
variants explain 761% of the variance in gender-adjusted Lp(a)
level. The strongest contribution was seen for rs9457951, which
explains 561% of the variance.
Using all JHS individuals, we also built a 10 SNP model by
stepwise linear regression for validation in other cohorts (see below).
Common Variants at LPA Explain Most of the Association
of Local Ancestry with Lp(a) Level
Many of the most highly correlated SNPs we identified are quite
differentiated in frequency between JHS-AFR-2LPA and JHS-
EUR-2LPA, and thus may explain the observed association of LPA
local ancestry with Lp(a) levels (Table S1, Table S2). We tested this
systematically for each SNP by comparing:
1. R
2: the adjusted R
2 for the regression of LPA local ancestry on
gender-adjusted Lp(a) level
2. R
2
geno: the adjusted R
2 for the regression of LPA local ancestry
on gender- and genotype-adjusted Lp(a) level
In principle, a statistic p=1-(R
2/R
2
geno) should give the
percentage of the ancestry-specific variation explained by the
SNP genotype. Table S2 shows p for the 10 SNPs that most
strongly account for the ancestry-specific variance. Each of these
10 SNPs has p.0.25, with 4 (rs7755463, rs9365166, rs9457951,
rs225830) having p.0.40. Thus a number of individual SNPs can
explain a large fraction of the observed association between LPA
local ancestry and Lp(a) level.
Since many of these SNPs are in linkage disequilibrium, we can
look for a multi-SNP model that explains a larger fraction of the
ancestry. We performed stepwise-model building, repeating five-
fold cross-validation, and testing the fitted model for explanation of
the local ancestry contribution to Lp(a) variance. We estimate that
common LPA variants explain 73613% of this ancestry association.
rs9457951 Is Strongly Associated with Isoform-adjusted
Lp(a) Levels in an Independent Population
To validate our results in an independent population, we
genotyped rs9457951 in 1,726 African Americans and 996
European Americans in DHS, and found a minor allele frequency
of 0.176 and 0.00253 respectively. The African Americans in DHS
had previously been genotyped using a panel of 2,270 genomewide
ancestry informative markers (Smith et al. 2004), allowing us to
generate global and local ancestry estimates. Furthermore, the
kringle(IV) CNV had also been genotyped in DHS [19], allowing
us to investigate the joint effects of isoform number, ancestry, and
rs9457951 on Lp(a) level.
DHSAfrican Americans had a mean of 15.8% European ancestry,
with mean Lp(a) levels of 97.9 nmol/L, compared to 56.2 nmol/L in
the DHS European Americans. Isoform number was a strong
predictor of Lp(a) level in DHS African Americans, with a
13.960.4% decrease in Lp(a) per unit increase in isoform number
(p=4.2610
2180), accounting for 40.7% of the Lp(a) variance. We
confirmed strong associations of Lp(a) with global ancestry (1363%
increase in Lp(a) per 10% increase in African ancestry proportion;
p=1.4 610
25)a n dl o c a la n c e s t r y( 9 61% increase in Lp(a) per 10%
increase in African ancestry, p=3.9610
213). These estimates were
reduced somewhat by adjustment for isoform number (1162% and
761%, respectively), indicating a modest correlation of isoform
number with global and local ancestry.
Genotype at rs9457951 was strongly associated with Lp(a) levels
in DHS after correction for global and local ancestry
(p=3.4610
29) and after additional correction for isoform number
(p=1.4610
224), with a large effect on unadjusted and isoform-
adjusted Lp(a) levels (2964% and 4163% per allele, respectively).
Figure 3. Pairwise linkage disequilibrium measures (r
2) for
significantly associated SNPs in the JHS African local ancestry
subpopulation.
doi:10.1371/journal.pone.0014581.g003
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the variance in isoform-adjusted Lp(a) levels. Figure 4 demon-
strates Lp(a) levels in DHS African Americans represented
according to their rs9457951 genotype and stratified by isoform
number, showing a marked effect across multiple isoforms.
Although the absolute change in Lp(a) level per rs9457951 allele
decreases with isoform number, the percentage change is relatively
constant, as evidenced by a non-significant genotype x isoform
interaction on log-transformed Lp(a) levels (p=0.14).
In addition to rs9457951, we investigated 3 SNPs that had
previously been reported to explain a large proportion of African-
European differences in Lp(a) level [10]. As the prior study had not
incorporated estimates of global and local ancestry, we wished to
analyze these SNPs with adjustment for ancestry and isoform
number. Of the 3 SNPs tested (rs1801693, G+1/inKIV-8A, and
T3888P (rs41272110)), rs1801693 explains 11% of the isoform-
and ancestry-adjusted variance, G+1inKIV-8A explains 3.7%, and
T3888P explains 32%. In a similar analysis, rs9457951 explains
36% of isoform- and ancestry-adjusted variance in Lp(a), while a
combination of T3888P and rs9457951 genotypes explains 56%.
rs9457951 is not Associated with Coronary Heart Disease
Outcomes in ARIC
We evaluated the 10 SNP model of common LPA variants that
we had discovered in JHS in 2200 African Americans from ARIC.
Table 2. Effect Size of LPA variants on Lp(a) levels.
SNP Allele fall fafr feur effectall ± seall effectafr ±seafr effecteur ±seeur p_int
rs2255830 T 0.776 0.847 0.422 14.562 16.563 6.364.3 0.126
rs2457550 T 0.872 0.918 0.727 13.862.5 16.563.8 1.464.9 0.0136
rs2136675 A 0.861 0.906 0.625 12.762.6 16.863.9 20.464.9 6.4E-03
rs9355803 C 0.927 0.949 0.814 11.363.3 11.164.9 11.466 0.860
rs2941382 G 0.95 0.976 0.856 14.9649 67.4 18.166.7 0.656
rs9365166 C 0.782 0.853 0.422 15.162 18.363 6.664.4 0.090
rs7754014 T 0.444 0.495 0.233 6.861.6 8.162.1 26.864.1 1.9E-03
rs7754188 T 0.305 0.325 0.222 11.461.8 1462.3 20.164.4 6.6E-03
rs9457930 T 0.795 0.869 0.439 14.362.1 15.463.3 764.5 0.176
rs3124787 T 0.866 0.918 0.6 12.362.6 16.564.1 0.565 0.013
rs6919346 C 0.965 0.994 0.81 27.564.7 36.8615.5 22.867 0.347
rs11751605 C 0.024 0.001 0.107 21.565.3 106.5646.4 31.867.1 0.800
rs1801693 G 0.865 0.917 0.614 14.762.5 19.4641 64.7 5.1E-03
rs7761293 A 0.763 0.838 0.381 7.7624 . 2 63 9.764.4 0.541
rs6415084 T 0.427 0.429 0.5 13.861.7 11.962.1 14.964 0.755
rs6922216 G 0.225 0.283 0 16.562 13.962.3 12.966.7 0.652
rs10455872 G 0.011 0.001 0.024 91.767.5 85.5639.1 116.869.9 0.113
rs7755463 T 0.364 0.45 0 11.961.7 10.762.1 13.265.8 0.440
rs6926458 A 0.892 0.915 0.833 14.262.7 14.664 9.265.5 0.306
rs6930542 C 0.183 0.234 0 25.962.1 20.362.5 25.467.5 0.360
rs9457951 G 0.192 0.249 0 25.462.2 20.262.5 2967.8 0.180
rs1321196 C 0.447 0.482 0.321 9.761.7 11.162.1 2.264 0.188
rs1652507 T 0.924 0.953 0.855 24.263.5 39.465.5 9.466.5 0.017
rs9346833 C 0.607 0.652 0.429 7.861.8 10.662.3 22.664.2 2.8E-04
The percent change in Lp(a) level per LPA allele is shown with standard error for the total population (effectall), JHS-AFR-2LPA (effectafr) and JHS-EUR-1_2LPA (effecteur)f o r
SNPs with pall,0.00085. The SNP frequencies of the allele producing higher Lp(a) levels in the total population (fall) are shown, along with the corresponding frequency
in JHS-AFR-2LPA (fafr) and JHS-EUR-2LPA (feur). The p-value for significance of interaction of genotype with local ancestry (p_int) is also shown.
doi:10.1371/journal.pone.0014581.t002
Figure 4. Variation of Serum Lp(a) with rs9457951 genotype in
African Americans in DHS, stratified by kringle(IV) copy
number. For genotypes CC and CG, the locally weighted scatterplot
smoothing curve was drawn; for genotype GG, the raw data were
plotted.
doi:10.1371/journal.pone.0014581.g004
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levels and DNA available, 1000 of these are also JHS participants
and had been included in the JHS analysis, so they were excluded
from validation of SNP and ancestry association with Lp(a) levels
in ARIC. We found strong association of local ancestry at the LPA
locus with Lp(a) level (p,2.2610
216) and confirmed association of
7 of the 10 SNPs at p,0.005 (Table S3). Furthermore, in keeping
with the cross-validation results in JHS, we found that our 10 SNP
model explained 71% of the association of local ancestry with
Lp(a) level. However, despite these strong associations with Lp(a)
level, we found no association of any of the 10 SNPs, or the 10
SNP model with the 389 incident CHD outcomes in the 3225
ARIC participants with surveillance data (Table S3). Furthermore,
no significant association was seen for global (p=0.14, b=20.76,
95% CI 21.79–0.25) or local ancestry with CHD outcomes
(p=0.31, b=0.12, 95% CI 20.11–0.34).
We were interested in determining whether we were adequately
powered to detect an effect of genotype on myocardial infarction.
Within ARIC, Lp(a) levels have weak associations with CHD
outcomes, with a previously reported relative risk of 1.15 for
African American women and 1.01 for African American men per
unit standard deviation in Lp(a) level (,100 mg/dL) [20]. As
relative risk and hazard ratios (HR) are not readily comparable, we
used the previously reported HR of 1.22 per doubling of Lp(a)
level [1] observed in European populations and estimated that we
would have to be powered to detect an HR of 1.07 for the
corresponding ,25% change in Lp(a) seen per allele of rs9457951.
Simulation-based power estimates using the exponential distribu-
tion to model survival times demonstrated that we with the 389
outcomes in ARIC, we only had 12% power to detect an HR of
1.07 or less at p,0.05 for the rs9457951 allele (see Methods).
Lp(a)-associated SNP Regions Harbor Potential
Transcription Factor Binding Sites
In addition to identifying SNPs that may contribute to disease
risk, genetic association studies have the potential to illuminate
the regulatory transcriptional architecture of quantitative traits.
Recent studies have mapped transcription factor motifs to DNA
sequences harboring genetic variants and have subsequently used
chromatin immunoprecipitation to demonstrate genotype-de-
pendent occupancy of the binding site [21]. To identify potential
transcription factor binding sites that may be influenced by
genetic variation at the Lp(a) locus, we scanned the genomic
sequences surrounding the 24 Lp(a) associated SNPs using Jaspar
(http://www.jaspar.genereg.net) and Transfac (http://www.
gene-regulation.com) positional weight matrices (PWMs) with
quantitative thresholds for match quality (see Methods). We
focused on transcription factorsw i t hp r e v i o u s l yd o c u m e n t e d
expression in liver (the site of Lp(a) production) and identified 7
SNPs for which genetic variation is likely to influence binding of
such transcription factors (Figure 5). The transcription factors for
the various SNPs include members of the GATA (rs3124787,
rs6919346, rs6926458), and Forkhead families (rs2255830,
rs2457550). Interestingly, the strongly associated rs6930542
SNP is expected to influence the binding of YY1, a ubiquitously
expressed transcription factor with potential for either activating
or repressive effects on gene expression [22]. In this case the C
allele associated with higher Lp(a) levels and higher frequencies
in African ancestral populations would be expected to disrupt
YY1 binding, suggesting that the baseline transcriptional effect of
YY1 at this site would be repressive. Further experiments in liver
tissue and/or cell lines will be needed to validate these
predictions.
Discussion
We have used a combination of admixture mapping and fine-
mapping adjusted for local ancestry to characterize the genetic
basis of interethnic differences in Lp(a) levels. Given that there is a
pronounced influence of global ancestry on Lp(a) levels within
African Americans (,10% change in Lp(a) per 10% increase in
African ancestry), genetic determinants of this association might, in
fact, explain much of the difference in Lp(a) levels between African
and European American populations. Towards this end, dense
fine-mapping identified common biallelic SNPs that account for
.70% of the global and local ancestry signal. Furthermore, the
observed, prominent peak of admixture association indicated that
variants differing in frequency between the African and European
ancestral populations are important determinants of Lp(a) level in
African Americans. One of these variants, rs9457951, explains up
to 5% of Lp(a) variance, and, in combination with additional
common SNPs, accounts for a total of 7% of variance.
We replicated the association of rs9457951 in the DHS cohort
and demonstrated that the effect of rs9457951 is even more
marked on isoform-adjusted Lp(a) levels. Similarly, rs9457951
explains a large proportion of the LPA local ancestry signal in
DHS. In contrast to the recently described association of biallelic
variants rs3798220 and rs10455872 with Lp(a) levels in Caucasian
populations [2], no single common biallelic LPA variant explains a
large proportion of variation in Lp(a) levels in African Americans.
This is most likely a reflection of limited linkage disequilibrium
between extreme kringle(IV) repeat numbers and common SNPs
on the African ancestral background and is in keeping with
recently observed genetic architecture for the Lp(a) locus in
Chinese and South-Asian populations [23]. In contrast to common
biallelic SNPs, kringle(IV) copy numbers explained .40% of Lp(a)
variance in DHS. Additional copy number variants and less
common biallelic variants within LPA and other genes are
expected to contribute to the remainder of the variance.
We further replicated the strong association of LPA local ancestry
with Lp(a) levels in a third large cohort of African Americans and
confirmed association of the majority of the SNPs in our multi-SNP
model. However, we found no significant association of any LPA
variant with CHD outcomes. This negative result can be attributed
in part to the lower contribution of individual biallelic variants on
Lp(a) levels in African Americans as compared to that seen for
European Americans [14] as evidenced by our low power (12%) to
detect the expected HR. It remains to be seen whether, with a much
largernumberofCHD cases,anassociationwithbiallelicvariantsin
the LPA genes will be seen in African Americans.
Methods
Ethics Statement
This study was conducted according to the principles expressed
in the Declaration of Helsinki. The study was approved by the
Institutional Review Board of the Jackson Heart Study, ARIC and
Dallas Heart Study. All patients provided written informed
consent for the collection of samples and subsequent analysis.
Selection of Case and Control samples
Participants in the discovery sample for this study (n=4605)
were all self-identified African Americans in the Jackson Heart
Study [2]. Between Sept. 2000 and March 2004, 5,301 African
Americans were recruited from three counties, Hinds, Rankin, and
Madison, which comprise the Jackson, MS metropolitan area.
Unrelated JHS participants were drawn from three sources in
roughly equal numbers: (1) former ARIC participants; (2)
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listing; and (3) a constrained volunteer sample for which
demographic cells for recruitment were designed to mirror the
overall target population. 4464 individuals were successfully
genotyped on the admixture panel [24,13,25]. DHS samples were
previously described in [26]. The ARIC study is a prospective
cohort study of 15,792 participants investigating the etiology of
atherosclerosis and described in detail elsewhere [27].
Lp(a) Assay
Serum Lp(a) was analyzed in JHS samples by a Diasorin
nephelometric assay on a Roche Cobas FARA analyzer [28].
Lp(a) was analyzed in DHS using a sandwich ELISA that is
insensitive to apo(a) isoform size [29]. Isoform number was
determined in DHS by immunoblot analysis with an LPA-specific
antibody [30]. Lp(a) was analyzed in ARIC using a double-
antibody ELISA [31].
Figure 5. Mapping of Lp(a) associated SNP regions to transcription factor binding motifs. Sequences surrounding each of the 24 Lp(a)
significantly associated SNPs were scanned for transcription factor binding motifs from the Transfac and Jaspar databases. Sequence logos for
binding motifs predicted to be disrupted by allelic variation are displayed along with the HGNC symbol of associated transcription factor and the
Jaspar or Transfac motif ID. Only transcription factors with literature evidence of liver expression are shown.
doi:10.1371/journal.pone.0014581.g005
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Linear regression analyses were used to evaluate association of
ancestry with Lp(a) levels. Association analyses were performed
using a combination of MERLIN [32] and R (www.Rproject.org).
MERLIN was used to obtain p-values and regression coefficients
over the entire cohort, accounting for the family structure among
related individuals in JHS. For cross-validation, which was needed
for accurate estimates of SNP contribution to Lp(a) variance (total
and ancestry-specific), we used R (2.9.1), which allowed greater
analytic flexibility. However, since we were unable to correct for
family structure in cross-validation analyses, we randomly selected
only one member of each family to be included in any given
analysis. To minimize bias, we generated 100 overlapping groups
of 3300 unrelated individuals and conducted all statistical analyses
on each set, averaging the results. The pairwise LD plot was
generated using the LDheatmap package in R.
Linear Regression Models
Lp(a) values in mg/dL were log transformed. Sex-adjusted Lp(a)
was used as the phenotype in association analyses with global
ancestry, local ancestry, and genotype – we did not see a
significant association of Lp(a) levels with age. For genotype-
phenotype association analyses, we assumed an additive mode of
inheritance and tested for the strength of association by ANOVA
[33] with nested linear regression models, which included global
ancestry, local ancestry, and local ancestry + genotype. The
genotype-local ancestry interaction term was computed as a
product of the local-ancestry term and SNP genotype, and is a
continuous variable ranging from of 0 to 2. We conducted separate
linear regression in a subset of 1831 individuals with a .95%
probability of two African ancestry alleles at the LPA locus and in a
subset of 615 individuals with a high (.95%) probability of 1 or
more European ancestral alleles (local ancestry .48% European
ancestry). We also identified a small subgroup of 46 individuals
with .95% probability of two European ancestral alleles JHS-
EUR-2LPA for calculation of allele frequencies and linkage
disequilibrium parameters (Table 1). Effect sizes were estimated
by evaluating what effect a unit change in genotype would have on
the predicted value of the trait.
Multi-SNP models were identified with stepwise linear regres-
sion and the anova function in R. For each of the 100 sets of 3300
unrelated individuals, the top SNP associated with the phenotype
residual of interest was identified and added to the regression
model. The remaining SNPs were then each tested sequentially by
ANOVA by comparing the model with and without the SNP and
adding the SNP to the model if the p-value for comparison was
,0.05. At each step this process was performed for each of the 100
sets of individuals and the average p-value for all sets was
determined. The process was continued until no additional SNP
improved the model at the p,0.05 threshold.
Cross-Validation for Assessment of Percentage of Lp(a)
Variance Explained
Cross validation was used for estimation of contribution of
individual SNPs and a multi-SNP model to Lp(a) variance. For
multi-SNP model assessment, each of the 100 groups of 3300
unrelated JHS individuals was randomly divided into 5 sets. For
each group, 3 sets were used for SNP discovery (p,0.05 for
association with sex and ancestry-adjusted Lp(a)), one used to build
a model by stepwise regression/ANOVA (including coefficient
estimation), and the fifth used as a test set to evaluate either the
percentage of residual variance or local-ancestry specific variance
explained. The roles of each set were rotated to obtain unbiased
estimates across the entire cohort. For single-SNP assessment, two-
fold cross-validation was performed, with one set used for
coefficient estimation and the second for determination of the
percentage of Lp(a) variance explained. The percentage of local
ancestry-specific variance in Lp(a) explained was calculated as
described in the Results section.
The local ancestry estimate at LPA was improved by forcing
rs9457951 into the set of markers used to estimate local ancestry.
This estimate was used for all analyses. Estimation of allele
frequencies and r
2 for SNPs was performed using the R GeneticsBase
package.
CHD Outcomes
We focused on 3225 African Americans in ARIC for this
analysis, excluding individuals based on the following criteria;
participants from centers with small numbers (n=55), prevalent
CHD (n=139), missing data for prevalent CHD (n=63), and
missing genotype data for the respective SNPs. The final analysis
sample included 389 incident CHD cases. Ascertainment and
standardized case definitions for CHD have been described
elsewhere [34]. Ten LPA SNPs were genotyped on stored DNA
using the TaqManH System. We tested for Hardy Weinberg
equilibrium using the x
2 goodness of fit test. Cox proportional
hazard regression was used to estimate the associations of SNPs
and incident events and linear regression was used for associations
of SNP genotype and ancestry with log-transformed Lp(a) levels.
All data were analyzed with STATA, Version 10.1.
Power calculations for rs9457951 were conducted by simulation
of the Cox Proportional Hazards Model in R as described [35].
We estimated that if the hazard ratio (HR) matched that seen in
[1], which was 1.22 for a doubling of Lp(a) level, we should see an
HR of 1.067 for a change in 25% in serum Lp(a), which is that
seen for inheritance of each allele of rs9457951 (or rs6390542). We
estimated our power to detect such an HR as follows. For each of
1000 iterations, using the estimated allele frequency in ARIC,
genotypes (zi) were randomly sampled for 3225 individuals. We
then simulated survival times for the i
th individual were generated
randomly using the exponential distribution, conditional on
genotype and HR, where the HR was drawn from a normal
distribution with mean=1.067 and standard deviation (as a
percentage of mean) matching that seen for age in the Cox
Proportional Hazards model. A survival time threshold for each
simulation was selected so that the number of CHD outcomes
matched that seen in ARIC (389). The significance of the
association of genotype with CHD outcome was determined using
the coxph function in R. The process was repeated 1000 times and
the percentage of significant associations (p,0.05) – which was
found to be 11.7% - was used to estimate power.
To determine case and control samples for admixture mapping,
individuals were ranked in terms of increasing gender-adjusted
Lp(a) level (age was not seen as a significant covariate), and the top
and bottom quintiles were used as cases and controls, respectively.
Admixture Mapping and Markov Chain Monte Carlo data
analysis for inference of ancestry and testing of disease
association. The ANCESTRYMAP software [17] was used for
all analyses. The program generates local ancestry estimates by
integrating information from a panel of densely spaced markers
differentiated in frequency between African and European
populations. The use of admixture mapping in JHS has been
described previously [13,24,25]. Briefly, we focused on the use of a
‘‘Cases-Only’’ statistic, looking at regions in the genome where the
local ancestry in Cases deviates significantly from the average
ancestry across the genome. The control population was used to
ensure that no artifact contributed to the increase in ancestry at
Ancestry and Lp(a) Levels
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ancestry in the opposite direction). Admixture peaks were defined
by regions where posterior LOD scores exceed 0. Bayesian 95%
credible intervals were then computed by plotting the posterior
LOD scores across the chromosome of interest and defining the
region centered on the maximum LOD score that included 95%
of the peak area.
Fine-Mapping Genotyping
Genotyping was performed on the Sequenom platform, which
utilizes matrix-assisted laser-desorption ionization time-of-flight
mass spectroscopy. SNPs with a genotype call rate ,90% (n=12)
and individuals with genotyping success rates ,f85% (n=141)
were excluded from analysis. Using Tagger [36], SNPs were
selected to tag the LPA gene (including 10 kb upstream and
downstream) locus at an r
2 of 1.0 with a minor allele frequency
(MAF) $2% in the Yoruba West African HapMap population
(YRI) using HapMap release #24. We then forced these SNPs into
Tagger to tag this region in CEU at an r
2 of 1.0 with MAF $2%.
Prediction of Transcription Factor Binding Sites at SNP
regions
Positional weight matrices (PWMs) for mammalian transcrip-
tion factors (TFs) were obtained from the Jaspar [37] (http://
www.jaspar.genereg.net) and Transfac [38] (http://www.
gene-regulation.com) databases. To compute a probability of
protein occupancy for each transcription factor at each site, a
previously described method was adapted [39]. Briefly, binding of
protein X to site i was modeled using the simple binding isotherm:
P~
½X 
Kd,X,iz½X 
where [X] is the free concentration of protein X and Kd,X,i is the
sequence-dependent dissociation constant for protein X at site i.
Although [X] is not known in most experimental situations, it can
be estimated as equal to the dissociation constant for the optimal
binding site in the genome, thus leading to a probability of
occupancy of 50% at optimal sites. The dissociation constant is
calculated from the free energy of binding, which in turn is
estimated from comparing the observed frequency fbj of base b at
each position j in the PWM with the background frequency of that
base pb in the genome:
Kd~e{DG=RT&e
{
P
RTln(fbj
.
pb)
RT ~e
{
P
ln(fbj
.
pb)
The genomic sequences 20 bases upstream and downstream of
each LPA SNP of interest were downloaded from the UCSC
Genome Browser (http://genome.ucsc.edu/). For each of the
1445 Transfac and Jaspar PWM’s a maximal probability of
occupancy was computed for sliding windows across the 41bp.
Motifs shown in Figure 5 correspond to transcription factors with
probabilities of occupancy .0.20 and a difference in probability
between the two alleles of .0.20. Results were robust to
probability ranges between 0.10 and 0.30. Identified transcription
factors were confirmed to have previously documented expression
in mammalian liver by consulting the Human Protein Reference
Database [40] (http://www.hprd.org) and PubMed (http://www.
pubmed.org).
Supporting Information
Figure S1 Pairwise linkage disequilibrium measures (r
2) for
significantly associated SNPs in the JHS European local ancestry
subpopulation.
Found at: doi:10.1371/journal.pone.0014581.s001 (13.62 MB
TIF)
Table S1 Association of LPA variants with Lp(a) levels. p-values
for association of Lp(a) with genotype in the total population (pall),
JHS-AFR-2LPA (pafr), and JHS-EUR-1_2LPA (peur). SNPs with
p,0.00085 are denoted by an asterisk. The SNP frequencies of
the allele producing higher Lp(a) levels in the total population (fall)
is shown, along with the corresponding frequency in JHS-AFR-
2LPA (fafr) and JHS-EUR-2LPA (feur). The chromosomal position in
bases (NCBI Build 36) is also provided.
Found at: doi:10.1371/journal.pone.0014581.s002 (0.14 MB
DOC)
Table S2 Effect of LPA variants on Association of LPA local
ancestry with Lp(a) levels. p, which is the fraction of ancestry-
specific variation in Lp(a) levels explained by genotype, is shown
for the genotyped SNPs that account for the greatest amount of
ancestry specific variance. The SNP frequencies and effect sizes in
the overall population are shown as in Table 2; pall is shown as in
Table S1.
Found at: doi:10.1371/journal.pone.0014581.s003 (0.06 MB
DOC)
Table S3 Effect of LPA variants on Lp(a) levels and CHD
outcomes in ARIC. P-values for association of SNPs with Lp(a)
levels in a linear regression model with age and gender are shown,
along with coefficients, confidence interval (CI) and p-value for
association with CHD outcomes in a Cox regression model. A p-
value for the significance of including 10 SNP genotypes in a
model to predict CHD outcomes was computed using the log-
likelihood ratio test.
Found at: doi:10.1371/journal.pone.0014581.s004 (0.07 MB
DOC)
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